Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades ResMed to Neutral

JP Morgan Downgrades ResMed to Neutral

JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral.

byBenzinga Newsdesk

August 12, 2022

1 minute read

JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral.

News

‘Manchester United Takeover: Club Still Negotiating Sale With Multiple Parties’ – BBC Sports

By Benzinga Newsdesk

June 15, 12:25 PM

https://www.bbc.com/sport/football/65921965 Negotiations around the potential sale of Manchester United are still taking place with multiple parties.Reuters reported on Thursday that United were negotiating

MANU

P/E Ratio Insights for American Express

By Benzinga Insights

November 23, 4:30 PM

In the current session, the stock is trading at $163.79, after a 0.92% increase. Over the past month,…

AXP

News

NeuBase Therapeutics Announces Strategic Restructuring Focused On Advancing Platform In Gene Editing, Announces Workforce Reductions Of About 60%

By Michael Horton

October 14, 4:08 PM

Workforce reductions of ~60% and implementation of a robust cost reduction plan are expected to extend the Company's cash runway into Q2 CY2024 The Company plans to maximize shareholder value by

NBSE